HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Equities research analysts at Northland Capmk raised their FY2026 earnings per share estimates for HIVE Blockchain Technologies in a report released on Tuesday, December 10th. Northland Capmk analyst M. Grondahl now anticipates that the company will earn $0.16 per share for the year, up from their prior estimate of $0.15. Northland Capmk has a “Strong-Buy” rating on the stock.
Other equities analysts also recently issued research reports about the company. HC Wainwright raised shares of HIVE Blockchain Technologies from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 15th. Cantor Fitzgerald upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Tuesday, October 29th.
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Further Reading
- Five stocks we like better than HIVE Blockchain Technologies
- What Does Downgrade Mean in Investing?
- The Great CPU Race: AMD and Intel Battle for Dominance
- 3 Warren Buffett Stocks to Buy Now
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- How to Effectively Use the MarketBeat Ratings Screener
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
